A cross‐sectional study comparing a blood test for methylated BCAT1 and IKZF1 tumor‐derived DNA with CEA for detection of recurrent colorectal cancer

Recurrence will develop in 30–50% of colorectal cancer (CRC) cases despite apparent clearance following treatment. Carcinoembryonic antigen (CEA) is the only guideline‐recommended blood test for monitoring cases for recurrence, but its sensitivity and specificity are suboptimal. This observational s...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cancer Med
Главные авторы: Young, Graeme P., Pedersen, Susanne K., Mansfield, Scott, Murray, David H., Baker, Rohan T., Rabbitt, Philippa, Byrne, Susan, Bambacas, Libby, Hollington, Paul, Symonds, Erin L.
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2016
Предметы:
Clinical Cancer Research
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5083729/
https://ncbi.nlm.nih.gov/pubmed/27726312
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.868
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы